Skip to content

The effect of L-arabinose on the glycaemic and insulinemic response after consumption of a liquid product.

The effect of L-arabinose on the glycaemic and insulinemic response after consumption of a liquid product. - Ara3-study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45701
Enrollment
24
Registered
2017-06-29
Start date
2017-08-07
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 2 metabolic diseases

Interventions

All products contain 50g sucrose and 250g water. The testproducts are: 1) Control sucrose solution (50g sucrose) 2) L-arabinose sucrose solution (Control + 5g L-arabinose) 3) Sucrose and fat solution

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18-35 years old while signing the informed consent - good Dutch writing, speaking, understanding - healthy: as judged by the participant - stable body weight, i.e. no reported weight loss or weight gain of >5kg in the two months prior to the screening session - normal Fasting glucose concentration 8.5 mmol/L for men and >7.5 mmol/L for females, measured by finger prick

Exclusion criteria

Exclusion criteria: - women being pregnant or lactating - allergy, intolerance or oversensitivity for food products - having a history of medical or surgical events that may affect the study outcome - having gastro-intestinal problems - medical drug use that may affect the study outcome - current antibiotics usage or in the two months prior to the screening session - not willing to eat or drink the test products - use of dietary supplements that may affect the study outcome - currently using a slimming or medically prescribed diet or having used one in the two months prior to the screening session - excessive alcohol consumption (*21 glasses/week on average) - planning to change physical activity pattern during the study period - having blood vessels that are too difficult for inserting a cannula, as judged by the study nurse - recent blood donation (

Design outcomes

Primary

MeasureTime frame
The primary outcomes are glycaemic and insulinemic response.

Secondary

MeasureTime frame
Secondary outcomes are: 1) appetite ratings, 2) subsequent ad libitum energy intake, 3) tolerance of the treatments, 4) gastro-entero endocrine markers, 5) L-arabinose in the blood, and 6) excretion of L-arabinose in urine.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)